Form 4: Yield10 Bioscience Director Acquires Shares in Lieu of Cash Compensation

Anthony J Sinskey, a director at Yield10 Bioscience, acquired 20,561 shares of common stock in lieu of cash compensation for services rendered.

Summary

• On March 28, 2024, Anthony J Sinskey, a director of Yield10 Bioscience, acquired 20,561 shares of common stock.
• These shares were issued in lieu of $7,813 in cash compensation for services rendered as a member of the Board of Directors and/or a committee thereof during the first quarter of 2024.
• Following the transaction, Sinskey's beneficial ownership of Yield10 Bioscience common stock is 64,274 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a standard compensation practice. The director taking shares instead of cash could be seen as a positive sign of confidence, but it's not a major event.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.

Industry Context

Director compensation in the form of stock is a common practice in publicly traded companies, aligning the interests of directors with those of shareholders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates

Keywords

Yield10 Bioscience, Director Compensation, Stock Acquisition, Form 4, YTEN, Beneficial Ownership, Anthony J Sinskey